Literature DB >> 16702742

Recruitment of patients for a clinical trial: factors on the physician side and reasons on the patient side.

Tsuguya Fukui1, Mahbubur Rahman, Takuro Shimbo, Satoshi Morita, Junichi Sakamoto.   

Abstract

OBJECTIVES: To examine the factors related to actual patient recruiters among the physicians who initially agreed to collaborate in a randomized control trial.
METHODS: We conducted a questionnaire survey of 679 physicians (512 actual recruiter and 167 non-recruiters) who had initially agreed to recruit patients for a clinical trial to determine factors to predict who would actually do so.
RESULTS: Response rates among recruiters and non-recruiters were 87.5% and 73.1%, respectively. Multivariate logistic regression model showed that the proportions of regular users of computer [odds ratio (OR) =2.1, 95% confidence intervals (CI)=1.3-3.3] (p=0.002) and current participants in other clinical trials (OR=2.2, CI=1.5-3.4) (p=0.001) were significantly higher among recruiters than non-recruiters. Patients' reasons for non-participation as perceived by the physicians did not differ between recruiters and non-recruiters.
CONCLUSION: Results of this study might be useful in predicting actual recruiters at the outset of clinical trials.

Entities:  

Mesh:

Year:  2006        PMID: 16702742     DOI: 10.2169/internalmedicine.45.1269

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  Recruitment of Ischemic Stroke Patients in Clinical trials in General Practice and Implications for Generalizability of Results.

Authors:  M Fareed; K Suri; Adnan I Qureshi
Journal:  J Vasc Interv Neurol       Date:  2012-06

2.  Preliminary results, methodological considerations and recruitment difficulties of a randomised clinical trial comparing two treatment regimens for patients with headache and neck pain.

Authors:  Willem De Hertogh; Peter Vaes; Dirk Devroey; Paul Louis; Hans Carpay; Steven Truijen; William Duquet; Rob Oostendorp
Journal:  BMC Musculoskelet Disord       Date:  2009-09-23       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.